Atrys Health Stock

Atrys Health FCF Margin

The Free Cash Flow Margin of Atrys Health (ATRY.MC) as of Jul 26, 2026 is -9.98 %. In the previous year, Free Cash Flow Margin was -4.77 % — a change of 109.42% (lower).

FCF Margin

-9.98 %

YoY

109.42%

Last updated:

Free Cash Flow Margin of Atrys Health is 2026 -9.98 % . Free Cash Flow Margin of Atrys Health was 2025 -4.77 % . It decreases by 109.42% lower compared to the previous year.
Access this data via the Eulerpool API

Atrys Health Stock analysis

What does Atrys Health do? Atrys Health SA is a leading provider of medical services, founded in 2007 in Madrid, Spain, as a spin-off company of the Clinica Universidad de Navarra. The company's goal is to connect the limitless world of science and technology with the human component of healthcare. The business model of Atrys Health specializes in the development of products, services, and solutions in the field of medical imaging and cancer treatment. The company offers innovative technologies and medical services to help diagnose and treat patients better. Atrys Health consists of different business divisions focusing on the needs of clinical practice, research and development, and biotechnological production. The company aims to improve the efficiency and effectiveness of diagnosis, imaging, and treatment technologies to maximize results. The divisions of Atrys Health focus on various aspects of healthcare, including telemedicine, radiology, and proton therapy. Telemedicine provides a platform for remote treatments and medical consultation, improving access to specialists and enabling fast and effective diagnosis and treatment. The radiology division operates diagnostic centers specializing in medical imaging, equipped with the latest imaging technologies. The proton therapy division operates a proton therapy center in Madrid, offering advanced cancer treatment. Atrys Health offers a range of products tailored to the needs of clinical practice, research and development, and biotechnological production. Their key products include Atrilab, a leading platform for precision oncology diagnostics, Auriculum, a technology for precise radiation in cancer treatments, and Vida Oncology, a software solution for cancer treatment management. In conclusion, Atrys Health is a key player in medical imaging and cancer treatment, improving healthcare globally with advanced technologies and services. With their vision of combining innovative technologies with the human component of healthcare, Atrys Health will continue to lead in the healthcare industry. Atrys Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Atrys Health stock

Free Cash Flow Margin of Atrys Health is -9.98 % in 2026.

Access this data via the Eulerpool API

Margins — Atrys Health

All Key Metrics — Atrys Health